JOSEPH MASCOLO: Open Payments
NPI 1962062927 · VERNON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 24 payments from 8 companies in 2025. Trend: 2023 $14 · 2024 $377 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 8 | $89 |
| ACADIA Pharmaceuticals Inc | 3 | $72 |
| Supernus Pharmaceuticals, Inc. | 6 | $70 |
| ABBVIE INC. | 2 | $51 |
| REVANCE THERAPEUTICS, INC. | 1 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Merz Pharmaceuticals, LLC | 1 | $38 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
Products named: Gocovri, NUPLAZID, Qelbree, DAXXIFY, INGREZZA, INBRIJA, BOTOX, CREXONT.
Industry payments across CT — which companies pay providers there.
